{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:11:08Z","timestamp":1789186268316,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejmg.2022.104499","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T03:33:28Z","timestamp":1649907208000},"page":"104499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-4240","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00dcnal Y\u00fcksekg\u00f6n\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Azak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u00e7ahan","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lker","family":"Ertu\u011frul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-5542","authenticated-orcid":false,"given":"G\u00fclen E.","family":"Utine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik","family":"Karag\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmg.2022.104499_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpam.2019.06.005","article-title":"Phenotypic variability in a series of four pediatric patients with Andersen-Tawil syndrome: a Saudi experience","volume":"6","author":"Alrashed","year":"2019","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/342360","article-title":"KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes","volume":"71","author":"Andelfinger","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nmd.2016.11.006","article-title":"Intrafamilial phenotypic variability in Andersen-Tawil syndrome: a diagnostic challenge in a potentially treatable condition","volume":"27","author":"Ardissone","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.ejmg.2022.104499_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.hrthm.2006.12.031","article-title":"Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome","volume":"4","author":"Bokenkamp","year":"2007","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ejmg.2022.104499_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1212\/01.wnl.0000178888.03767.74","article-title":"Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation","volume":"65","author":"Davies","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ejmg.2022.104499_bib6","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/europace\/eut160","article-title":"Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation","volume":"15","author":"Delannoy","year":"2013","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ejmg.2022.104499_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/pace.13204","article-title":"Response to flecainide test in Andersen-Tawil syndrome with incessant ventricular tachycardia","volume":"41","author":"Fern\u00e1ndez","year":"2018","journal-title":"Pacing Clin. Electrophysiol.: PACE (Pacing Clin. Electrophysiol.)"},{"issue":"2","key":"10.1016\/j.ejmg.2022.104499_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.yjmcc.2004.05.011","article-title":"Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome","volume":"37","author":"Fodstad","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.ejmg.2022.104499_bib9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eun180","article-title":"Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome","volume":"10","author":"Fox","year":"2008","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.59.3.466","article-title":"Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome","volume":"59","author":"Junker","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejmg.2022.104499_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1540-8167.2004.03369.x","article-title":"Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome","volume":"15","author":"Kannankeril","year":"2004","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejmg.2022.104499_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jelectrocard.2019.10.009","article-title":"Therapeutic management of ventricular arrhythmias in Andersen-Tawil syndrome","volume":"58","author":"Maffe","year":"2020","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ejmg.2022.104499_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2014.11.157","article-title":"Abnormal electroencephalogram, epileptic seizures, structural congenital heart disease and aborted sudden cardiac death in Andersen-Tawil syndrome","volume":"180","author":"Marquez","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hrthm.2014.12.009","article-title":"Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations","volume":"12","author":"Miyamoto","year":"2015","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ejmg.2022.104499_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8167.2007.00910.x","article-title":"Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome","volume":"19","author":"Pellizzon","year":"2008","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ejmg.2022.104499_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.ejmg.2022.104499_bib17","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.hrthm.2006.07.021","article-title":"A family with Andersen-Tawil syndrome and dilated cardiomyopathy","volume":"3","author":"Schoonderwoerd","year":"2006","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.hrthm.2007.12.012","article-title":"Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome","volume":"5","author":"Sumitomo","year":"2008","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ejmg.2022.104499_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1442-200x.2005.02024.x","article-title":"KCNJ2 mutation in intractable ventricular arrhythmia with Andersen's syndrome","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr. Int."},{"issue":"11","key":"10.1016\/j.ejmg.2022.104499_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.nmd.2017.09.001","article-title":"Clinical heterogeneity in Andersen-Tawil syndrome","volume":"27","author":"Totomoch-Serra","year":"2017","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ejmg.2022.104499_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00424-010-0820-6","article-title":"Kir 2.1 channelopathies: the Andersen-Tawil syndrome","volume":"460","author":"Tristani-Firouzi","year":"2010","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"3","key":"10.1016\/j.ejmg.2022.104499_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.ejmg.2022.104499_bib23","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721222000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:18Z","timestamp":1761709938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721222000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1769721222000805"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104499","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of flecainide in bidirectional ventricular tachycardia and tachycardia-induced cardiomyopathy with Andersen-Tawil syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2022.104499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104499"}}